XML 31 R5.htm IDEA: XBRL DOCUMENT v3.2.0.727
Note 1. The Company
6 Months Ended
Jun. 30, 2015
Notes  
Note 1. The Company

Note 1. The Company

American Biogenetic Sciences, Inc. (the "Company", “We” or the "Registrant") was incorporated in Delaware on September 1, 1983. Prior to ceasing its operations in 2002, the Company was engaged in the research, development and production of bio-pharmaceutical products. On September 19, 2002, the Registrant filed for bankruptcy under the U.S. Bankruptcy Code in the U.S. Bankruptcy Court Eastern District of New York. On November 4, 2005, the Company emerged from Bankruptcy Court. On August 13, 2010, the Company's sole officer/director transferred and assigned his control stock position to an unrelated third party but remained as the Company's sole executive officer/director. On April 14, 2015, the Company incorporated a subsidiary in Delaware for the purpose of acquiring real estate. To date, the control shares have not been issued.